|
|
|
|
Headache remedy may defend from breast cancer
Aspirin, ibuprofen named in study Pamela Fayerman, Vancouver Sun; Canwest News Service Published: Thursday, October 09, 2008 Women taking certain medications for aches and pains may be getting a surprise bonus -- protection against breast...
|
|
|
GSK, Theravance announce positive phase-2b results for asthma drug
GlaxoSmithKline Plc (GSK) and Theravance, Inc announced positive results from the phase-2b study of the novel, long-acting beta agonist (LABA) GW642444 ('444) in patients with moderate to severe asthma.The study, which was designed to...
|
|
|
Got A Headache? It Is Your Dentist, Not Doctor Who Could Fix It!
Headaches, migraines, pain behind our eyes, sinus, and even neck and shoulder pain are all ailments that would warrant a trip to the doctors - that is until now.As Rahul Doshi and Ashish B. Parmar, award-winning cosmetic dentist's from...
|
|
|
Treatment of Sinus Headache as Migraine: The Diagnostic Utility of Triptans
Kari E et al.- This study demonstrated that the demographics of patients with self-described 'sinus headaches' who did not have findings of sinusitis on endoscopy and CT scan closely reflected the demographics of patients afflicted with...
|
|
|
GSK and Theravance announce positive phase 2b results for LABA, '444 in the Horizon Asthma Development program
Initial results demonstrate potential of '444 in the treatment of patients with moderate to severe asthma London UK and South San Francisco, CA GlaxoSmithKline Plc (GSK) and Theravance, Inc.(NASDAQ: THRX) today announced positive results...
|
|
|
GSK and Theravance Announce Positive Phase 2b Results for LABA, '444 in the Horizon Asthma Development Program
-- GlaxoSmithKline Plc (GSK) and Theravance, Inc.(NasdaqGM:THRX - News) today announced positive results from the phase 2b study of the novel, long-acting beta agonist (LABA) GW642444 ('444) in patients with moderate to severe asthma.
|
|
|
GlaxoSmithKline (GSK) (JOBS) and Theravance, Inc. (THRX) Announce Positive Phase 2b Results for LABA, '444 in
-- GlaxoSmithKline Plc (GSK) and Theravance, Inc.(NasdaqGM:THRX - News) today announced positive results from the phase 2b study of the novel, long-acting beta agonist (LABA) GW642444 ('444) in patients with moderate to severe asthma.
|
|
|
Acupuncture Beats Aspirin For Chronic Headache, Duke University Study
Duke University Academic - Research Clinical - Research Academic - Research (World) Clinical - Research (World) Pain control About Biospace| Contact Us | Privacy Statement | Terms of Use Post Your News| Post Event | Post Jobs | Post Company...
|
|
|
GSK and Theravance Announce Positive Phase 2b Results for LABA, '444 in the Horizon Asthma Development Program
- GlaxoSmithKline Plc (GSK) and Theravance, Inc.(NASDAQ Further evidence of once-daily efficacy was observed in a number of secondary endpoints including improvements in peak expiratory flow both in the morning and evening, and the...
|
|
|
GSK and Theravance Announce Positive Phase 2b Results for LABA, '444 in the Horizon Asthma Development Program
GlaxoSmithKline Plc (GSK) and Theravance, Inc.(NASDAQ: THRX) today announced positive results from the phase 2b study of the novel, long-acting beta agonist (LABA) GW642444 ('444) in patients with moderate to severe asthma. The study,...
|
|
|
GSK and Theravance Announce Positive Phase 2b Results for LABA, '444 in the Horizon Asthma Development Program
-- GlaxoSmithKline Plc (GSK) and Theravance, Inc.(NasdaqGM:THRX - News) today announced positive results from the phase 2b study of the novel, long-acting beta agonist (LABA) GW642444 ('444) in patients with moderate to severe asthma.
|
|
|
GSK and Theravance Announce Positive Phase 2b Results for LABA, '444 in the Horizon Asthma Development Program
-- GlaxoSmithKline Plc (GSK) and Theravance, Inc.(NasdaqGM:THRX - News) today announced positive results from the phase 2b study of the novel, long-acting beta agonist (LABA) GW642444 ('444) in patients with moderate to severe asthma.
|
|
|
Thunderclap Headache and Normal Computed Tomographic Results: Value of Cerebrospinal Fluid Analysis
Journal of the American College of Cardiology, 10/21/08 International Journal of Thunderclap Headache and Normal Computed Tomographic Results: Value of Cerebrospinal Fluid Analysis.
|
|
|
Headache diary helps diagnosis
Patients who suffer from headache should record their symptoms in a headache diary to help diagnosis, according to clinical guidelines.The diagnosis and management of headache in adults, published by the , emphasises that limited...
|
|
|
Telcagepant Safe, Effective in Migraine Treatment
Results of a randomized trial show that telcagepant, also known as MK-0974, is effective in the treatment of migraine, with efficacy similar to zolmitriptan 5 mg (Zolmig, AstraZeneca) but with fewer adverse effects.The study, presented...
|
|
|
Migraine treatment
Dr Tony W Ho MD a , Prof Michel D Ferrari MD b, Prof David W Dodick MD c, Vince Galet PhD a, James Kost PhD a, Xiaoyin Fan PhD a, Heather Leibensperger BS a, Samar Froman BS a, Christopher Assaid PhD a, Christopher Lines PhD a, Hille Koppen...
|
|
|
Telcagepant Proven As A Safe And Effective Migraine Treatment In Phase III Trial
Telcagepant 300 mg is effective as an acute treatment for migraine with efficacy comparable to that of zolmitriptan 5 mg, a widely-used migraine treatment, but with fewer associated adverse effects.These are the conclusions of an Article...
|
|
|
Acupuncture for the Management of Chronic Headache: A Systematic Review
The Internet Journal of Anesthesiology, 11/03/08 Journal of Alternative and Comp Acupuncture for the Management of Chronic Headache: A Systematic Review.
|
|
|
Headache and Migraine - Studies from Leiden University update current data on headache and migraine
'Mammalian circadian rhythms are driven by the circadian pacemaker of the suprachiasmatic (SCN) and are synchronized to the external 24-hour light/dark cycle.After advance time zone transitions (eastbound jet lag), overt circadian rhythms...
|
|
|
Overuse of Narcotics, Barbiturates May Exacerbate Migraine
-- Medications containing barbiturates or narcotics may have the unintended consequence of increasing the frequency of migraine attacks, according to a study published in a recent issue of the journal, Headache.The study also found...
|
|
|
Case 36-2008 - A 59-Year-Old Man with Chronic Daily Headache
_ Case 36-2008 - A 59-Year-Old Man with Chronic Daily Headache.
|
|
|
Medications containing barbiturates or narcotics may make migraine worse
A team of researchers led by investigators at the Albert Einstein College of Medicine of Yeshiva University has determined that certain commonly-prescribed medications may have the unintended consequence of increasing the frequency of...
|
|
|
Headache, blindness and a seizure after childbirth
_ Headache, blindness and a seizure after childbirth.
|
|
|
IPCA to organise seminar on innovative Ayurveda treatment for migraine
The Mumbai-based IPCA Laboratories will organise a seminar in Mumbai on November 20 on the benefits of its innovative Ayurveda treatment protocol for migraine.The seminar will analyse the products available in the market for migraine...
|
|
|
Headache of a diagnosis: frontotemporal pain and inflammation associated with osteolysis
A 62-year-old woman presented with left frontotemporal pain, scalp tenderness and raised levels of inflammatory markers.Temporal arteritis was considered likely, and symptoms resolved with prednisone therapy. This delayed diagnostic...
|
